CD8A and metastatic neoplasm: To characterize the functional phenotype of APhigh versus AP−/low MoMs, we isolated CD74hi and CD74−/low MoMs (F4/80+TIM4−) from early and advanced metastatic tumors using FACS and co-cultured them with activated CD8+ T cells.